1-7 of 7
Donald K. Hamlin
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 928: Glypican-3 targeted thorium-227 alpha therapy reduces tumor burden in an orthotopic xenograft model of hepatocellular carcinoma

Kevin P. Labadie, Donald K. Hamlin, Aimee Kenoyer, Sara K. Daniel, Alan F. Utria, Andrew D. Ludwig, Heidi L. Kenerson, Delphine L. Chen, Johnnie Orozco, Raymond S. Yeung, Lily Li, Chris Orvig, Yawen Li, D Scott Wilbur, James O. Park
Journal: Cancer Research
Cancer Res (2021) 81 (13_Supplement): 928.
https://doi.org/10.1158/1538-7445.AM2021-928
Published: 01 July 2021
View article titled, Abstract 928: Glypican-3 targeted thorium-227 alpha therapy reduces tumor burden in an orthotopic xenograft model of hepatocellular carcinoma
Journal Articles

Venetoclax Synergizes with Radiotherapy for Treatment of B-cell Lymphomas

Shyril O'Steen, Damian J. Green, Ajay K. Gopal, Johnnie J. Orozco, Aimee L. Kenoyer, Yukang Lin, D. Scott Wilbur, Donald K. Hamlin, Darrell R. Fisher, Mark D. Hylarides, Theodore A. Gooley, Amelia Waltman, Brian G. Till, Oliver W. Press
Journal: Cancer Research
Cancer Res (2017) 77 (14): 3885–3893.
https://doi.org/10.1158/0008-5472.CAN-17-0082
Published: 13 July 2017
View article titled, Venetoclax Synergizes with Radiotherapy for Treatment of B-cell Lymphomas
Open the PDF for Venetoclax Synergizes with Radiotherapy for Treatment of B-cell Lymphomas in another window
Includes: Supplementary data
Journal Articles

Comparative Analysis of Bispecific Antibody and Streptavidin-Targeted Radioimmunotherapy for B-cell Cancers

Damian J. Green, Shani L. Frayo, Yukang Lin, Donald K. Hamlin, Darrell R. Fisher, Sofia H.L. Frost, Aimee L. Kenoyer, Mark D. Hylarides, Ajay K. Gopal, Theodore A. Gooley, Johnnie J. Orozco, Brian G. Till, Shyril O'Steen, Kelly D. Orcutt, D. Scott Wilbur, K. Dane Wittrup, Oliver W. Press
Journal: Cancer Research
Cancer Res (2016) 76 (22): 6669–6679.
https://doi.org/10.1158/0008-5472.CAN-16-0571
Published: 14 November 2016
View article titled, Comparative Analysis of Bispecific Antibody and Streptavidin-Targeted Radioimmunotherapy for B-cell Cancers
Open the PDF for Comparative Analysis of Bispecific Antibody and Streptavidin-Targeted Radioimmunotherapy for B-cell Cancers in another window
Includes: Supplementary data
Journal Articles

A Preclinical Model of CD38-Pretargeted Radioimmunotherapy for Plasma Cell Malignancies

Damian J. Green, Nural N. Orgun, Jon C. Jones, Mark D. Hylarides, John M. Pagel, Donald K. Hamlin, D.S. Wilbur, Yukang Lin, Darrell R. Fisher, Aimee L. Kenoyer, Shani L. Frayo, Ajay K. Gopal, Johnnie J. Orozco, Theodore A. Gooley, Brent L. Wood, William I. Bensinger, Oliver W. Press
Journal: Cancer Research
Cancer Res (2014) 74 (4): 1179–1189.
https://doi.org/10.1158/0008-5472.CAN-13-1589
Published: 16 February 2014
View article titled, A Preclinical Model of CD38-Pretargeted Radioimmunotherapy for Plasma Cell Malignancies
Open the PDF for A Preclinical Model of CD38-Pretargeted Radioimmunotherapy for Plasma Cell Malignancies in another window
Includes: Supplementary data
Journal Articles

Biodistributions, Myelosuppression, and Toxicities in Mice Treated with an Anti-CD45 Antibody Labeled with the α-Emitting Radionuclides Bismuth-213 or Astatine-211

Hirohisa Nakamae, D. Scott Wilbur, Donald K. Hamlin, Monica S. Thakar, Erlinda B. Santos, Darrell R. Fisher, Aimee L. Kenoyer, John M. Pagel, Oliver W. Press, Rainer Storb, Brenda M. Sandmaier
Journal: Cancer Research
Cancer Res (2009) 69 (6): 2408–2415.
https://doi.org/10.1158/0008-5472.CAN-08-4363
Published: 17 March 2009
View article titled, Biodistributions, Myelosuppression, and Toxicities in Mice Treated with an Anti-CD45 Antibody Labeled with the α-Emitting Radionuclides Bismuth-213 or Astatine-211
Open the PDF for Biodistributions, Myelosuppression, and Toxicities in Mice Treated with an Anti-CD45 Antibody Labeled with the α-Emitting Radionuclides Bismuth-213 or Astatine-211 in another window
Includes: Supplementary data
Journal Articles

Pretargeted Radioimmunotherapy Using Anti-CD45 Monoclonal Antibodies to Deliver Radiation to Murine Hematolymphoid Tissues and Human Myeloid Leukemia

John M. Pagel, Dana C. Matthews, Aimee Kenoyer, Donald K. Hamlin, Daniel S. Wilbur, Darrell R. Fisher, Ajay K. Gopal, Yukang Lin, Laura Saganic, Frederick R. Appelbaum, Oliver W. Press
Journal: Cancer Research
Cancer Res (2009) 69 (1): 185–192.
https://doi.org/10.1158/0008-5472.CAN-08-2513
Published: 31 December 2008
View article titled, Pretargeted Radioimmunotherapy Using Anti-CD45 Monoclonal Antibodies to Deliver Radiation to Murine Hematolymphoid Tissues and Human Myeloid Leukemia
Open the PDF for Pretargeted Radioimmunotherapy Using Anti-CD45 Monoclonal Antibodies to Deliver Radiation to Murine Hematolymphoid Tissues and Human Myeloid Leukemia in another window
Journal Articles

Evaluation of CD20, CD22, and HLA-DR Targeting for Radioimmunotherapy of B-Cell Lymphomas

John M. Pagel, Anastasia Pantelias, Nathan Hedin, Shani Wilbur, Laura Saganic, Yukang Lin, Donald Axworthy, Donald K. Hamlin, D. Scott Wilbur, Ajay K. Gopal, Oliver W. Press
Journal: Cancer Research
Cancer Res (2007) 67 (12): 5921–5928.
https://doi.org/10.1158/0008-5472.CAN-07-0080
Published: 15 June 2007
View article titled, Evaluation of CD20, CD22, and HLA-DR Targeting for Radioimmunotherapy of B-Cell Lymphomas
Open the PDF for Evaluation of CD20, CD22, and HLA-DR Targeting for Radioimmunotherapy of B-Cell Lymphomas in another window